Centro de Investigación de Medicina Aplicada (CIMA)
Centro / Instituto vinculado a la Universidad de Navarra
Hospital Universitario Araba
Vitoria, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Araba (15)
2024
-
Immune dysfunction prior to and during vaccination in multiple myeloma: a case study based on COVID-19
Blood Cancer Journal, Vol. 14, Núm. 1
2023
-
Association of adiposity and its changes over time with COVID-19 risk in older adults with overweight/obesity and metabolic syndrome: a longitudinal evaluation in the PREDIMED-Plus cohort
BMC Medicine, Vol. 21, Núm. 1
-
Intensive Weight-Loss Lifestyle Intervention Using Mediterranean Diet and COVID-19 Risk in Older Adults: Secondary Analysis of PREDIMED-Plus Trial
Journal of Nutrition, Health and Aging, Vol. 27, Núm. 12, pp. 1162-1167
2021
-
Immune biomarkers to predict SARS-CoV-2 vaccine effectiveness in patients with hematological malignancies
Blood Cancer Journal, Vol. 11, Núm. 12
-
Lenalidomide and dexamethasone with or without clarithromycin in patients with multiple myeloma ineligible for autologous transplant: a randomized trial
Blood Cancer Journal, Vol. 11, Núm. 5
2017
-
Chronic lymphocytic leukemia with isochromosome 17q: An aggressive subgroup associated with TP53 mutations and complex karyotypes
Cancer Letters, Vol. 409, pp. 42-48
2016
-
Molecularly determined total tumour load in lymph nodes of stage I–II colon cancer patients correlates with high-risk factors. A multicentre prospective study
Virchows Archiv, Vol. 469, Núm. 4, pp. 385-394
2008
-
DRD3, but not COMT or DRD2, genotype affects executive functions in healthy and first-episode psychosis adolescents
American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics, Vol. 147, Núm. 6, pp. 873-879
-
The genetic contribution to first psychotic episodes in children and adolescents of the child and adolescent first-episode psychosis study
Psychiatric Genetics, Vol. 18, Núm. 3, pp. 151-152
2007
-
The child and adolescent first-episode psychosis study (CAFEPS): Design and baseline results
Schizophrenia Research, Vol. 91, Núm. 1-3, pp. 226-237
2006
2005
-
Amplification of IGH/MYC fusion in clinically aggressive IGH/BCL2-positive germinal center B-cell lymphomas
Genes Chromosomes and Cancer, Vol. 43, Núm. 4, pp. 414-423
2004
-
Clinical variability of patients with the t(6;8)(q27;p12) and FGFR1OP-FGFR1 fusion: Two further cases
Hematology Journal, Vol. 5, Núm. 6, pp. 534-537
-
Cryptic ins(2;11) with clonal evolution showing amplification of 11q23-q25 either on hsr(11) or on dmin, in a patient with AML-M2 [4]
Leukemia
-
Remission of acute monocytic leukemia, secondary to treatment with epipodophyllotoxins, in a patient with t(8;16)(p11;p13) and MYST3-CREBBP fusion [5]
Cancer Genetics and Cytogenetics